Related Experiment Video
Updated: Jun 9, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
Primary lung signet-ring cell carcinoma: a national analysis
Arian Mansur1, Zain Saleem2, Alexandra L Potter3
1Harvard Medical School, Boston, MA, USA.
Primary lung signet-ring cell carcinoma (LSRCC) is an aggressive cancer with distinct features. This study identified key characteristics and survival predictors for LSRCC patients, highlighting differences from lung adenocarcinoma.
Area of Science:
- Oncology
- Pathology
- Epidemiology
Background:
- Primary lung signet-ring cell carcinoma (LSRCC) is a rare and aggressive lung cancer.
- Its clinical features and prognostic factors are not well understood.
Purpose of the Study:
- To evaluate the clinicopathological characteristics of primary LSRCC.
- To identify independent prognostic factors for patients with primary LSRCC.
Main Methods:
- Retrospective analysis of the National Cancer Database (2004-2018).
- Comparison of overall survival (OS) using Kaplan-Meier and multivariable Cox proportional hazards models.
- Identification of independent prognostic indicators for LSRCC.
Main Results:
- 1,705 LSRCC, 504,006 lung adenocarcinoma (LAC), and 15,883 lung mucinous adenocarcinoma (LMAC) patients were analyzed.
- LSRCC was associated with younger age, male sex, larger/poorly differentiated tumors, and advanced stage.
- LSRCC patients had significantly worse OS compared to LAC and LMAC in unadjusted analysis, and worse OS than LAC in multivariable analysis.
Conclusions:
- LSRCC exhibits distinct clinicopathological characteristics compared to LAC.
- Independent predictors of survival for LSRCC include younger age, later diagnosis year, lower comorbidity score, lower AJCC stage, higher income, smaller tumors, and treatment with surgery and chemotherapy.
More Related Videos
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024